Trial intelligence / Profile preview

TXA and IV Iron for Hip Fracture Surgery

NCT02428868Unknown

Sponsor
Institut Mohamed Kassab d'Orthopédie
Start
Apr 2015
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of tranexamic acid and iron sucrose in anemia (3 arms), sponsored by Institut Mohamed Kassab d'Orthopédie. Primary endpoint: Percentage of patients who receive red-cell transfusion at 5 days. Status: unknown.

02

Drugs

tranexamic acidiron sucrose
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02428868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02428868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call